Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT05059860
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of Type 1 diabetes
* Established on the Tandem pump for at least 1 month, using novorapid or humalog insulin
* HbA1c 40-90 mmol/mol inclusive within the previous 30 days or taken at screening
* Total daily dose of insulin 10-100 units
* Willing to attend study visits and complete all study assessments
* Able to give informed consent
Exclusion Criteria:
* Pregnant or planning pregnancy
* Any disorder which, in the investigators' opinion might jeopardise the patient's safety or compliance with the protocol
* Life expectancy less than one year
* Severe renal impairment (eGFR \<30ml/min)
* Weight \<25kg
* Patients prescribed hydroxycarbamide
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05059860
Study Brief:
Protocol Section:
NCT05059860